Insurance and cost

TMS Insurance Coverage in New York: Preparing for Approval

The TMS Therapy New York editorial teamEditorial review
September 23, 20268 min read
Key takeaway

New York insurers may cover TMS for depression if medical necessity is documented, including diagnosis, prior treatments and a provider plan, with approval varying by policy.

TMS Insurance Coverage in New York: Preparing for Approval

Transcranial magnetic stimulation (TMS) may be covered by some health insurance plans in New York when it is recommended for depression and meets the insurer’s clinical requirements. However, coverage is not automatic. Most insurers ask for evidence that TMS is medically necessary before they approve treatment.

Preparing your records early can make the prior authorisation process clearer and may help avoid delays. The exact requirements depend on your individual plan, whether it is employer-sponsored, individual cover, Medicare, Medicaid managed care or a Medicare Advantage plan, and the clinical details of your situation.

TMS Therapy New York lists 223 published clinics across the state. Clinics may be able to check benefits and explain the documents they need, but the insurer makes the final coverage decision.

What insurers commonly look for

Insurers usually assess whether TMS is appropriate for a person with major depressive disorder whose symptoms have not improved sufficiently with standard treatments. TMS was cleared by the FDA for major depressive disorder in 2008, and for depression with comorbid anxiety in 2021.

Coverage criteria differ, but insurers commonly request evidence in several areas:

  • A diagnosis of major depressive disorder
  • Current depression symptoms that are clinically significant
  • Previous treatment with antidepressant medication
  • A history of psychotherapy or an explanation of why therapy is not suitable or available
  • Ongoing care from an appropriate prescribing clinician or mental health professional
  • Documentation showing why TMS is being recommended now
  • A treatment plan from the TMS provider

Some policies are written in detailed clinical language. Others use broader terms such as “treatment-resistant depression” or “failure of adequate treatment trials”. These phrases can sound discouraging, but they generally refer to whether previous treatment has been tried at an appropriate dose and for an appropriate duration, rather than whether a person has “failed” personally.

Documented medication trials

Medication history is often one of the most important parts of a TMS authorisation request. Many insurers want records showing that more than one antidepressant has been tried without sufficient improvement, or that medication caused significant side effects or could not be continued safely.

An insurer may ask for details such as:

  • The name of each medication
  • The dose prescribed
  • How long it was taken
  • Whether the dose was adjusted
  • Why it was stopped or changed
  • Whether symptoms improved, stayed the same or worsened
  • Any side effects that affected treatment

The key issue is usually whether each medication trial was adequate. A prescription that was stopped after a very short time may not meet a plan’s definition of an adequate trial, unless there was a documented reason such as a serious adverse effect. Similarly, an insurer may need to see that the medicine was taken as prescribed where possible.

If you have changed GPs, psychiatrists or health systems, parts of your medication history may be held in different places. It can be useful to request records from previous prescribers rather than relying only on your memory. Your current clinician may also be able to prepare a concise medication summary for the TMS provider.

Do not stop, start or alter medication in order to meet insurance requirements. Any medication decision should be made with the clinician who prescribes it.

Therapy and other treatment history

Many insurers also ask about psychotherapy, particularly evidence-based talking therapies used for depression. This does not necessarily mean that everyone must have had the same type or length of therapy. Requirements vary by plan and by clinical circumstances.

Useful records may include confirmation that you attended therapy, a treatment summary from your therapist, or notes from your psychiatrist or GP describing previous therapy. The documents may state:

  • The type of therapy received
  • Roughly when treatment took place
  • Whether you attended regularly
  • Your response to treatment
  • Whether therapy is continuing alongside other care

Some people cannot access regular therapy because of availability, cost, transport, work, caring responsibilities or clinical reasons. If this applies to you, discuss it openly with your treating clinician. They can record relevant context in the authorisation request where appropriate.

Insurance approval for TMS does not replace the need for ongoing mental health care. Your insurer or TMS clinic may expect you to remain under the care of a psychiatrist, prescribing clinician or other mental health professional during treatment.

Symptom scores and clinical assessments

Insurers commonly want a clear picture of current symptoms and how they have changed over time. Clinics and mental health professionals often use standard depression questionnaires or rating scales to support this assessment.

These symptom scores can help show the severity of depression before TMS begins and provide a baseline for monitoring progress. Your clinician may also document symptoms such as low mood, loss of interest, disrupted sleep, changes in appetite, poor concentration, fatigue, guilt or hopelessness.

If you have completed depression questionnaires during appointments, ask whether those scores are included in your records. If you have not, a TMS assessment will often include them. Scores should be completed honestly; they are not a test to pass, but one part of a clinical assessment.

The insurer may also ask for information about safety. This can include a review of seizure history, neurological conditions, implanted devices, current medicines and other factors relevant to TMS. Seizure is a rare risk of TMS, while scalp discomfort and headache are among the more common side effects.

How prior authorisation works

Prior authorisation is the insurer’s review before it agrees to pay for a planned treatment. For TMS, the request is often submitted by the clinic that will provide treatment, although the referring psychiatrist or another clinician may supply supporting records.

A typical process may look like this:

  1. Initial consultation: A TMS clinician reviews your diagnosis, treatment history and suitability for treatment.
  1. Benefits check: The clinic contacts your insurer to check whether your plan includes TMS benefits, whether prior authorisation is required and whether there are network rules.
  1. Records collection: You provide consent for the clinic to request or receive records from current and previous clinicians.
  1. Submission: The clinic sends the insurer the clinical notes, medication history, symptom measures and proposed treatment plan.
  1. Insurer review: The insurer may approve, deny or ask for more information.
  1. Decision and scheduling: If approved, the clinic explains the authorised treatment and any patient costs. If further information is needed, the clinic may contact you or your clinicians.

A standard TMS course is often around 36 weekday sessions delivered over six to nine weeks. Insurance approval may refer to an initial set of sessions, with further review needed if additional treatment is requested. Ask the clinic what the authorisation covers and whether it includes assessment, treatment sessions and follow-up appointments.

Checking your New York plan

New York residents may encounter plans from Empire BlueCross BlueShield, EmblemHealth or HIP, Fidelis Care, Aetna, Cigna, UnitedHealthcare or Oxford, NY Medicaid Managed Care, or Medicare, including Medicare Advantage plans. These insurers do not all use the same criteria, and different plans under the same insurer can have different networks and benefit rules.

When calling the member services number on your insurance card, consider asking:

  • Is TMS covered for my diagnosis under my specific plan?
  • Is prior authorisation required?
  • Must I use an in-network TMS clinic?
  • Does my plan require a referral?
  • What clinical criteria apply?
  • What are my deductible, co-payment or co-insurance responsibilities?
  • Is there a limit on the number of sessions covered?
  • What happens if the authorisation is denied?

Write down the date of the call, the name of the representative and any reference number provided. This can be useful if there is later confusion about benefits.

Medicare coverage and Medicare Advantage coverage may not work in the same way. Likewise, NY Medicaid Managed Care plans can have their own processes. It is worth checking the requirements directly rather than assuming that a friend’s experience or information online will apply to your policy.

Gathering records before your appointment

A simple folder, whether paper or digital, can make the process easier. Include records that are available, but do not delay seeking an assessment just because your file is incomplete. The clinic may help identify what is missing.

Useful items include:

  • Your insurance card and photo identification
  • Contact details for your GP, psychiatrist, therapist and previous prescribers
  • A list of current and previous psychiatric medicines
  • Pharmacy records, if available
  • Psychiatric evaluations and recent clinical notes
  • Therapy summaries or attendance information
  • Previous depression questionnaire scores
  • Hospital discharge summaries, where relevant
  • Details of any previous TMS, ketamine or electroconvulsive therapy treatment

Be accurate about dates where you can, but approximate dates are better than leaving important treatment history out altogether. If you are unsure why a medication was changed, say so. Your clinician can review the record rather than making assumptions.

If authorisation is denied

A denial does not always mean TMS is permanently unavailable. Sometimes the insurer needs more records, clarification about medication trials or a revised submission. Ask for the denial reason in writing and discuss it with the TMS clinic and your treating clinician.

You may have appeal rights through your health plan. The clinic may be able to provide supporting clinical information, while your psychiatrist or GP can explain why TMS has been recommended. Keep copies of letters, authorisation decisions and communications with the insurer.

Getting help in New York

Use the TMS Therapy New York clinic listings to find published providers across the state, including listings in New York, Buffalo, Rochester, Albany, White Plains, Syracuse and other communities. The directory’s insurance guide can help you prepare questions for your plan, and the contact page is available for help using the directory.

This is educational information, not medical advice.

This page is informational and is not medical advice.

Ready to talk to a New York clinic?

Send one request and we'll match you with providers who take your insurance.

This form is not for medical emergencies — call 911 or dial 988.

Keep reading

Find a Provider